Showing results (441-450 of 782) with videos related to

Sort By:
Pageof 79
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trialsJohn Koreth, Corey S Cutler, Benjamin Djulbegovic, et al.
Blood|May 12, 2005
A SCID-hu in vivo model of human Waldenström macroglobulinemiaPierfrancesco Tassone, Paola Neri, Jeffery L Kutok, et al.
Molecular Cancer Therapeutics|October 14, 2003
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myelomaMasood A Shammas, Robert J Shmookler Reis, Masaharu Akiyama, et al.
British Journal of Haematology|October 20, 2017
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myelomaDanka Cholujova, Zdenka Bujnakova, Erika Dutkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK StudyNoopur Raje, Robert Vescio, Charles W Montgomery, et al.
Expert Review of Hematology|January 26, 2012
Management of myeloma-associated renal dysfunction in the era of novel therapiesMahmoud R Gaballa, Jacob P Laubach, Robert L Schlossman, et al.
Oncogene|August 13, 2002
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implicationsConstantine S Mitsiades, Nicholas Mitsiades, Vassiliki Poulaki, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Molecular Cancer Therapeutics|April 15, 2018
Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of ElotuzumabAhmed T Kurdi, Siobhan V Glavey, Natalie A Bezman, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Pageof 79